semaglutide glasgow New Wegovy weight loss jab 'hope' for thousands in Monday announcement - full list of who qualifies NHS England to offer weight-loss

Wegovy (semaglutide) is a prescription GLP1 receptor agonist indicated for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weightrelated comorbidity (e.g., hypertension, type 2 diabetes, dyslipidemia)

Because food stays in your stomach longer, you feel full for a greater period

FRAX is available in print and online and does not require a DEXA scan, making it useful for initial risk stratification in clinical settings where imaging may not be immediately accessible

Others are designed to be lower in carbs or sugar, making them easier to fit into a diabetes-friendly eating plan